NLRP3 and Hepatitis: The critical role of IL-1β/NLRP3 in the pathogenesis of ConA-induced hepatitis was also supported by an intervention study using an IL-1R antagonist that suppressed hepatic inflammation by diminishing ROS production and NLRP3 inflammasome activation [93].